beta
Trial Radar IA

Discutiamo ed esploriamo gli studi clinici con AstraZeneca come promotore principale o collaboratore.

Mostrando gli studi clinici per Diabete.

Posso aiutarti a capire le condizioni di salute, i trattamenti o a trovare studi clinici vicini.
Il nostro strumento di ricerca supporta solo l'inglese. Per la ricerca e la discussione in altre lingue, usa Trial Radar IA sopra o seleziona i filtri per condizione medica e luogo (qui sotto).
381 risultati trovati
Primi 50 visualizzati
  
Patologia
Diabete
×
 
Tipo
Farmaco
×
 
Titolo dello studio
Stato
Renal Mechanism of Action/Splay vs. TmG (MOA) NCT00726505
Terminato
Chinese Multiple Dose Escalation (MDE) High Dose Study (COTA China PK) NCT05437848
Completato
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus NCT02229383
CompletatoRisultati pubblicati
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus NCT00108004
Completato
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin NCT00701935
TerminatoRisultati pubblicati
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes NCT00064714
Completato
Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus NCT01095991
Completato
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus NCT01082120
Completato
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo NCT02229396
CompletatoRisultati pubblicati
Uno studio per valutare l'effetto di AZD6793 sulla farmacocinetica e farmacodinamica della metformina in partecipanti con diabete mellito di tipo 2 (IRAK4) NCT07433062
In arruolamento
Impact of Diabetes on Left Ventricular Remodeling (P3) NCT01052272
CompletatoRisultati pubblicati
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE) NCT06579105
Completato
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus NCT02500979
CompletatoRisultati pubblicati
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone NCT02419612
CompletatoRisultati pubblicati
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old NCT03199053
CompletatoRisultati pubblicati
Evaluation of the Effect of Pramlintide on Satiety and Food Intake NCT00042601
Completato
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients NCT04445714
CompletatoRisultati pubblicati
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas NCT00313313
CompletatoRisultati pubblicati
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients NCT01152385
CompletatoRisultati pubblicati
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00316082
CompletatoRisultati pubblicati
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes NCT00229658
CompletatoRisultati pubblicati
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients NCT00972244
CompletatoRisultati pubblicati
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00327015
CompletatoRisultati pubblicati
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients NCT01020123
CompletatoRisultati pubblicati
Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study (FORTUNA) NCT01140542
Completato
Phase III Insulin Add-On Asia Regional Program - ST NCT02096705
CompletatoRisultati pubblicati
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus NCT00313183
Completato
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus (DERISC) NCT02426541
CompletatoRisultati pubblicati
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus NCT01206647
Sconosciuto
A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT02367066
CompletatoRisultati pubblicati
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease (PLANET 1) NCT00296374
CompletatoRisultati pubblicati
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients NCT00658463
Completato
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) NCT06099067
Completato
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT01165268
Completato
Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes NCT03377335
Sconosciuto
Bioequivalence Study NCT01874080
Completato
GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes NCT00229710
Terminato
Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes NCT04556760
CompletatoRisultati pubblicati
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS) NCT01991795
CompletatoRisultati pubblicati
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients NCT01055652
Completato
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus NCT00226330
Terminato
Evaluation of the Bioavailability of Pramlintide NCT00042471
Completato
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus NCT00135330
CompletatoRisultati pubblicati
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus NCT01876849
Completato
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin (GENERATION) NCT01006603
CompletatoRisultati pubblicati
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214
CompletatoRisultati pubblicati
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2) NCT02460978
CompletatoRisultati pubblicati
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus NCT00107107
Completato
Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes (PROMPT) NCT01006590
CompletatoRisultati pubblicati
Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice (FLORA) NCT02719132
Ritirato